Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin-15 is a transmembrane cell-adhesion protein encoded by the *PCDH15* gene and is essential for normal function in the cochlea and retina. Protocadherin-15 is a member of the cadherin superfamily of calcium-dependent cell-adhesion proteins. It consists of 11 extracellular cadherin repeats, a transmembrane domain, and a unique cytoplasmic domain. In the inner ear, protocadherin-15 and cadherin-23 form filamentous tip links that convey forces to mechanotransduction channels, allowing sound sensation. Its structure allows for flexibility and mechanical gating critical for auditory function. Protocadherin-15 is also essential in retinal cell maintenance. Mutations in the *PCDH15* gene are linked to autosomal recessive disorders, including Usher syndrome type 1F, characterized by deafness, balance problems, and progressive blindness. Variations in the gene can produce a spectrum of phenotypes, from full syndromic presentation to isolated hearing loss. There is currently no evidence of its direct druggability or modulation by approved therapeutics.
Not applicable; no drugs are known to target this molecule directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin-15 (PCDH15).